S&P 500   5,090.77 (+0.07%)
DOW   39,161.24 (+0.24%)
QQQ   436.87 (-0.27%)
AAPL   182.58 (-0.97%)
MSFT   410.31 (-0.33%)
META   483.15 (-0.61%)
GOOGL   143.85 (-0.17%)
AMZN   174.34 (-0.14%)
TSLA   192.36 (-2.56%)
NVDA   791.28 (+0.75%)
NIO   5.45 (-6.84%)
AMD   176.48 (-2.96%)
BABA   75.92 (-0.26%)
T   16.84 (+1.51%)
F   12.14 (+0.17%)
MU   85.88 (-0.03%)
CGC   3.36 (-0.30%)
GE   153.19 (+1.00%)
DIS   107.68 (+0.04%)
AMC   4.47 (+1.13%)
PFE   27.83 (+1.02%)
PYPL   59.18 (+1.42%)
XOM   104.01 (-0.72%)
S&P 500   5,090.77 (+0.07%)
DOW   39,161.24 (+0.24%)
QQQ   436.87 (-0.27%)
AAPL   182.58 (-0.97%)
MSFT   410.31 (-0.33%)
META   483.15 (-0.61%)
GOOGL   143.85 (-0.17%)
AMZN   174.34 (-0.14%)
TSLA   192.36 (-2.56%)
NVDA   791.28 (+0.75%)
NIO   5.45 (-6.84%)
AMD   176.48 (-2.96%)
BABA   75.92 (-0.26%)
T   16.84 (+1.51%)
F   12.14 (+0.17%)
MU   85.88 (-0.03%)
CGC   3.36 (-0.30%)
GE   153.19 (+1.00%)
DIS   107.68 (+0.04%)
AMC   4.47 (+1.13%)
PFE   27.83 (+1.02%)
PYPL   59.18 (+1.42%)
XOM   104.01 (-0.72%)
S&P 500   5,090.77 (+0.07%)
DOW   39,161.24 (+0.24%)
QQQ   436.87 (-0.27%)
AAPL   182.58 (-0.97%)
MSFT   410.31 (-0.33%)
META   483.15 (-0.61%)
GOOGL   143.85 (-0.17%)
AMZN   174.34 (-0.14%)
TSLA   192.36 (-2.56%)
NVDA   791.28 (+0.75%)
NIO   5.45 (-6.84%)
AMD   176.48 (-2.96%)
BABA   75.92 (-0.26%)
T   16.84 (+1.51%)
F   12.14 (+0.17%)
MU   85.88 (-0.03%)
CGC   3.36 (-0.30%)
GE   153.19 (+1.00%)
DIS   107.68 (+0.04%)
AMC   4.47 (+1.13%)
PFE   27.83 (+1.02%)
PYPL   59.18 (+1.42%)
XOM   104.01 (-0.72%)
S&P 500   5,090.77 (+0.07%)
DOW   39,161.24 (+0.24%)
QQQ   436.87 (-0.27%)
AAPL   182.58 (-0.97%)
MSFT   410.31 (-0.33%)
META   483.15 (-0.61%)
GOOGL   143.85 (-0.17%)
AMZN   174.34 (-0.14%)
TSLA   192.36 (-2.56%)
NVDA   791.28 (+0.75%)
NIO   5.45 (-6.84%)
AMD   176.48 (-2.96%)
BABA   75.92 (-0.26%)
T   16.84 (+1.51%)
F   12.14 (+0.17%)
MU   85.88 (-0.03%)
CGC   3.36 (-0.30%)
GE   153.19 (+1.00%)
DIS   107.68 (+0.04%)
AMC   4.47 (+1.13%)
PFE   27.83 (+1.02%)
PYPL   59.18 (+1.42%)
XOM   104.01 (-0.72%)

AcelRx Pharmaceuticals (ACRX) Short Interest Ratio & Short Volume

AcelRx Pharmaceuticals Short Interest Data

Current Short Volume
508,100 shares
Previous Short Volume
520,600 shares
Change Vs. Previous Month
-2.40%
Dollar Volume Sold Short
$411,052.90
Short Interest Ratio / Days to Cover
3.2
Last Record Date
December 15, 2023
Outstanding Shares
16,950,000 shares
Float Size
16,070,000 shares
Short Percent of Float
3.16%
Today's Trading Volume
243,500 shares
Average Trading Volume
137,683 shares
Today's Volume Vs. Average
177%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling AcelRx Pharmaceuticals ?

Sign up to receive the latest short interest report for AcelRx Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ACRX Short Interest Over Time

ACRX Days to Cover Over Time

ACRX Percentage of Float Shorted Over Time


AcelRx Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/15/2023508,100 shares $411,052.90 -2.4%3.2%3.2 $0.81
11/30/2023520,600 shares $382,641.00 -30.7%3.2%2.5 $0.74
11/15/2023751,400 shares $361,423.40 -1.1%4.7%3.3 $0.48
10/31/2023759,900 shares $395,148.00 -10.9%4.9%2.4 $0.52
10/15/2023852,700 shares $544,534.22 +22.9%5.5%2.8 $0.64
9/30/2023693,900 shares $402,462.00 +8.7%4.5%2.3 $0.58
9/15/2023638,100 shares $587,052.00 +0.4%4.1%2.4 $0.92
8/31/2023635,300 shares $654,359.00 -46.2%4.2%2.9 $1.03
8/15/20231,180,000 shares $902,700.00 +14.6%7.6%5.6 $0.77
7/31/20231,030,000 shares $1.06 million +19.7%6.6%8.7 $1.03
7/15/2023860,800 shares $1.04 million -0.8%8.0%6.9 $1.21
6/30/2023867,400 shares $962,814.00 +0.9%8.0%6.9 $1.11
6/15/2023859,900 shares $1.07 million 0.0%8.0%5.4 $1.24
5/31/2023860,000 shares $856,560.00 +12.3%8.0%3.9 $1.00
5/15/2023765,800 shares $604,982.00 -10.5%7.1%3.7 $0.79
4/30/2023855,800 shares $573,386.00 +2.4%7.9%3.9 $0.67
4/15/2023835,900 shares $578,860.75 +2.5%7.8%3.6 $0.69
3/31/2023815,600 shares $536,664.80 +17.5%7.6%3.5 $0.66
3/15/2023694,100 shares $492,811.00 +4.1%8.6%3.1 $0.71
2/28/2023666,600 shares $946,572.00 +7.9%8.3%4.3 $1.42
2/15/2023617,600 shares $981,984.00 +15.5%7.7%3.7 $1.59
1/31/2023534,900 shares $1.07 million -16.5%6.6%3 $2.00
1/15/2023640,700 shares $1.66 million -12.3%8.0%3.7 $2.59
12/30/2022730,900 shares $1.65 million -16.8%9.1%4.8 $2.26
12/15/2022878,500 shares $2.12 million +12.5%12.0%6.7 $2.41
11/30/2022780,600 shares $1.87 million -0.4%10.7%6.3 $2.39
11/15/2022783,500 shares $1.97 million +28.7%10.7%7.1 $2.52
10/31/2022608,700 shares $1.61 million -93.9%8.5%4.6 $2.64
10/15/20229,980,000 shares $2.16 million -0.1%N/A4.7 $0.22
9/30/20229,990,000 shares $2.09 million -10.8%N/A4.3 $0.21
9/15/202211,200,000 shares $3.04 million -0.4%N/A3.6 $0.27
8/31/202211,250,000 shares $3.32 million -19.9%N/A3.6 $0.30
8/15/202214,040,000 shares $4.29 million +17.1%N/A4.6 $0.31
7/31/202211,990,000 shares $2.47 million +7.0%N/A5.6 $0.21
7/15/202211,210,000 shares $2.59 million +81.4%N/A5.4 $0.23
6/30/20226,180,000 shares $1.51 million +1.0%9.2%3.1 $0.24
6/15/20226,120,000 shares $1.22 million +61.5%9.1%4.7 $0.20
5/31/20223,790,000 shares $860,330.00 +54.7%N/A2.8 $0.23
5/15/20222,450,000 shares $514,255.00 +18.4%N/A2.2 $0.21
4/30/20222,070,000 shares $516,879.00 +6.2%N/A2 $0.25













ACRX Short Interest - Frequently Asked Questions

What is AcelRx Pharmaceuticals' current short interest?

Short interest is the volume of AcelRx Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of December 15th, investors have sold 508,100 shares of ACRX short. 3.16% of AcelRx Pharmaceuticals' shares are currently sold short. Learn More on AcelRx Pharmaceuticals' current short interest.

What is a good short interest ratio for AcelRx Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACRX shares currently have a short interest ratio of 3.0. Learn More on AcelRx Pharmaceuticals's short interest ratio.

Which institutional investors are shorting AcelRx Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AcelRx Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for AcelRx Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.16% of AcelRx Pharmaceuticals' floating shares are currently sold short.

Is AcelRx Pharmaceuticals' short interest increasing or decreasing?

AcelRx Pharmaceuticals saw a decline in short interest during the month of December. As of December 15th, there was short interest totaling 508,100 shares, a decline of 2.4% from the previous total of 520,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is AcelRx Pharmaceuticals' float size?

AcelRx Pharmaceuticals currently has issued a total of 16,950,000 shares. Some of AcelRx Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. AcelRx Pharmaceuticals currently has a public float of 16,070,000 shares.

How does AcelRx Pharmaceuticals' short interest compare to its competitors?

3.16% of AcelRx Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to AcelRx Pharmaceuticals: NeuroSense Therapeutics Ltd. (1.45%), Cocrystal Pharma, Inc. (0.04%), Indaptus Therapeutics, Inc. (0.25%), RenovoRx, Inc. (0.09%), Onconova Therapeutics, Inc. (0.26%), VBI Vaccines Inc. (1.39%), Xilio Therapeutics, Inc. (0.01%), TFF Pharmaceuticals, Inc. (0.86%), Akari Therapeutics, Plc (0.04%), RedHill Biopharma Ltd. (3.76%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($4.67 billion), General Motors ($4.33 billion), T-Mobile US, Inc. ($4.30 billion), Charter Communications, Inc. ($3.12 billion), Coinbase Global, Inc. ($3.12 billion), Occidental Petroleum Co. ($2.94 billion), Tractor Supply ($2.71 billion), Rivian Automotive, Inc. ($2.32 billion), United Rentals, Inc. ($2.22 billion), and Royal Caribbean Cruises Ltd. ($2.04 billion). View all of the most shorted stocks.

What does it mean to sell short AcelRx Pharmaceuticals stock?

Short selling ACRX is an investing strategy that aims to generate trading profit from AcelRx Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against AcelRx Pharmaceuticals?

A short squeeze for AcelRx Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ACRX, which in turn drives the price of the stock up even further.

How often is AcelRx Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACRX, twice per month. The most recent reporting period available is December, 15 2023.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ACRX) was last updated on 2/23/2024 by MarketBeat.com Staff